• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对结构明确的 Aβ 寡聚体模拟物产生的抗体在亚化学计量浓度下可保护人诱导多能干细胞神经元免受 Aβ 毒性作用。

Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations.

作者信息

Ruttenberg Sarah M, Dhaoui Rakia, Kreutzer Adam G, Nowick James S

机构信息

Department of Chemistry, University of California, Irvine, California, United States of America.

Department of Pharmaceutical Sciences, University of California, Irvine, California, United States of America.

出版信息

PLoS One. 2025 Sep 8;20(9):e0331024. doi: 10.1371/journal.pone.0331024. eCollection 2025.

DOI:10.1371/journal.pone.0331024
PMID:40920787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416638/
Abstract

Anti-Aβ antibodies are important tools for identifying structural features of aggregates of the Aβ peptide and are used in many aspects of Alzheimer's disease (AD) research. Our laboratory recently reported the generation of a polyclonal antibody, pAb2AT-L, that is moderately selective for oligomeric Aβ over monomeric and fibrillar Aβ and recognizes the diffuse peripheries of Aβ plaques in AD brain tissue but does not recognize the dense fibrillar plaque cores. This antibody was generated against 2AT-L, a structurally defined Aβ oligomer mimic composed of three Aβ-derived β-hairpins arranged in a triangular fashion and covalently stabilized with three disulfide bonds. In the current study, we set out to determine if pAb2AT-L is neuroprotective against toxic aggregates of Aβ and found that pAb2AT-L protects human iPSC-derived neurons from Aβ42-mediated toxicity at molar ratios as low as 1:100 antibody to Aβ42, with a ratio of 1:25 almost completely rescuing cell viability. Few other antibodies have been reported to exhibit neuroprotective effects at such low ratios of antibody to Aβ. ThT and TEM studies indicate that pAb2AT-L delays but does not completely inhibit Aβ42 fibrillization at sub-stoichiometric ratios. The ability of pAb2AT-L to inhibit Aβ42 toxicity and aggregation at sub-stoichiometric ratios suggests that pAb2AT-L binds toxic Aβ42 oligomers and does not simply sequester monomeric Aβ42. These results further suggest that toxic oligomers of Aβ42 share significant structural similarities with 2AT-L.

摘要

抗淀粉样前体蛋白(Aβ)抗体是识别Aβ肽聚集体结构特征的重要工具,在阿尔茨海默病(AD)研究的许多方面都有应用。我们实验室最近报道了一种多克隆抗体pAb2AT-L的产生,该抗体对寡聚体Aβ的选择性高于单体和纤维状Aβ,能识别AD脑组织中Aβ斑块的弥散周边,但不能识别致密的纤维状斑块核心。这种抗体是针对2AT-L产生的,2AT-L是一种结构明确的Aβ寡聚体模拟物,由三个呈三角形排列的Aβ衍生β-发夹组成,通过三个二硫键共价稳定。在本研究中,我们着手确定pAb2AT-L是否对Aβ的毒性聚集体具有神经保护作用,结果发现pAb2AT-L能以低至1:100的抗体与Aβ42摩尔比保护人诱导多能干细胞衍生的神经元免受Aβ42介导的毒性,1:25的比例几乎能完全挽救细胞活力。很少有其他抗体被报道在如此低的抗体与Aβ比例下表现出神经保护作用。硫黄素T(ThT)和透射电子显微镜(TEM)研究表明,pAb2AT-L在亚化学计量比下会延迟但不会完全抑制Aβ42纤维化。pAb2AT-L在亚化学计量比下抑制Aβ42毒性和聚集的能力表明,pAb2AT-L结合有毒的Aβ42寡聚体,而不仅仅是隔离单体Aβ42。这些结果进一步表明,Aβ42的有毒寡聚体与2AT-L具有显著的结构相似性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/290ea2ef8f35/pone.0331024.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/56513e5e2ada/pone.0331024.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/4ca97fe78448/pone.0331024.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/c0db961188df/pone.0331024.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/644dffdda3f1/pone.0331024.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/290ea2ef8f35/pone.0331024.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/56513e5e2ada/pone.0331024.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/4ca97fe78448/pone.0331024.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/c0db961188df/pone.0331024.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/644dffdda3f1/pone.0331024.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d08/12416638/290ea2ef8f35/pone.0331024.g005.jpg

相似文献

1
Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations.针对结构明确的 Aβ 寡聚体模拟物产生的抗体在亚化学计量浓度下可保护人诱导多能干细胞神经元免受 Aβ 毒性作用。
PLoS One. 2025 Sep 8;20(9):e0331024. doi: 10.1371/journal.pone.0331024. eCollection 2025.
2
Identification of the binding site and immunoreactivity of anti-Aβ antibody 11A1: Comparison with the toxic conformation-specific TxCo-1 antibody.抗Aβ抗体11A1结合位点及免疫反应性的鉴定:与毒性构象特异性TxCo-1抗体的比较
Biochem Biophys Res Commun. 2025 Apr 12;758:151655. doi: 10.1016/j.bbrc.2025.151655. Epub 2025 Mar 17.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Synthesis and mechanistic investigation of short peptides as Aβ aggregation inhibitors.作为β淀粉样蛋白聚集抑制剂的短肽的合成及机理研究
Bioorg Chem. 2025 Aug;163:108756. doi: 10.1016/j.bioorg.2025.108756. Epub 2025 Jul 15.
5
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
6
Amyloid beta 1-40 and 1-42 fibril ratios and maturation level cause conformational differences with minimal impact on autophagy and cytotoxicity.淀粉样β 1-40 和 1-42 纤维比率和成熟度水平导致构象差异,对自噬和细胞毒性的影响最小。
J Neurochem. 2024 Sep;168(9):3308-3322. doi: 10.1111/jnc.16201. Epub 2024 Aug 12.
7
Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation.来自人诱导多能干细胞衍生神经干细胞的细胞外囊泡可保护人类神经元免受Aβ-42寡聚体诱导的神经退行性变、线粒体功能障碍和tau蛋白磷酸化。
Stem Cell Res Ther. 2025 Apr 18;16(1):191. doi: 10.1186/s13287-025-04324-3.
8
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis.在检测脑淀粉样变性方面,血浆pTau217与Aβ42的比值比单独测量更具优势。
medRxiv. 2025 Jan 10:2024.12.07.24318640. doi: 10.1101/2024.12.07.24318640.
9
Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation.球状淀粉样β蛋白寡聚体通过促进纤维伸长,具有多种促进淀粉样β蛋白聚集的机制。
Neurobiol Dis. 2025 Feb;205:106775. doi: 10.1016/j.nbd.2024.106775. Epub 2024 Dec 22.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Generation and Study of Antibodies against Two Triangular Trimers Derived from Aβ.针对源自淀粉样前体蛋白(Aβ)的两种三角形三聚体的抗体的产生与研究
Pept Sci (Hoboken). 2024 Mar;116(2). doi: 10.1002/pep2.24333. Epub 2023 Sep 18.
2
A turn for the worse: Aβ β-hairpins in Alzheimer's disease.病情恶化:阿尔茨海默病中的 Aβ β-发夹。
Bioorg Med Chem. 2024 May 1;105:117715. doi: 10.1016/j.bmc.2024.117715. Epub 2024 Apr 10.
3
Antibodies Raised Against an Aβ Oligomer Mimic Recognize Pathological Features in Alzheimer's Disease and Associated Amyloid-Disease Brain Tissue.
针对Aβ寡聚体模拟物产生的抗体可识别阿尔茨海默病及相关淀粉样疾病脑组织中的病理特征。
ACS Cent Sci. 2023 Dec 21;10(1):104-121. doi: 10.1021/acscentsci.3c00592. eCollection 2024 Jan 24.
4
A single-domain antibody detects and neutralises toxic Aβ oligomers in the Alzheimer's disease CSF.一种单域抗体可检测和中和阿尔茨海默病 CSF 中的毒性 Aβ 寡聚物。
Alzheimers Res Ther. 2024 Jan 18;16(1):13. doi: 10.1186/s13195-023-01361-z.
5
A Hairpin Motif in the Amyloid-β Peptide Is Important for Formation of Disease-Related Oligomers.发夹基序在淀粉样β肽中对于形成与疾病相关的寡聚体很重要。
J Am Chem Soc. 2023 Aug 23;145(33):18340-18354. doi: 10.1021/jacs.3c03980. Epub 2023 Aug 9.
6
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line.T1AM/TAAR1 系统可减轻人小神经胶质细胞 HMC3 株的炎症反应和 β-淀粉样毒性。
Int J Mol Sci. 2023 Jul 17;24(14):11569. doi: 10.3390/ijms241411569.
7
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future.阿尔茨海默病的淀粉样β为基础的治疗:挑战、成功与未来。
Signal Transduct Target Ther. 2023 Jun 30;8(1):248. doi: 10.1038/s41392-023-01484-7.
8
Dual Efficacy of a Catalytic Anti-Oligomeric Aβ42 scFv Antibody in Clearing Aβ42 Aggregates and Reducing Aβ Burden in the Brains of Alzheimer's Disease Mice.催化抗寡聚 Aβ42 scFv 抗体在清除 Aβ42 聚集物和减少阿尔茨海默病小鼠大脑中 Aβ 负担方面的双重功效。
Mol Neurobiol. 2023 Oct;60(10):5515-5532. doi: 10.1007/s12035-023-03406-8. Epub 2023 Jun 16.
9
Early events in amyloid-β self-assembly probed by time-resolved solid state NMR and light scattering.时间分辨固态 NMR 和光散射研究淀粉样-β自组装的早期事件。
Nat Commun. 2023 May 23;14(1):2964. doi: 10.1038/s41467-023-38494-6.
10
Probing differences among Aβ oligomers with two triangular trimers derived from Aβ.用两个源自 Aβ 的三角形三聚体探测 Aβ 寡聚物的差异。
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2219216120. doi: 10.1073/pnas.2219216120. Epub 2023 May 22.